newsfilter
← Latest News
Business Wire·

Pear Therapeutics and BrightView Health Expand Pilot Program to Provide Prescription Digital Therapeutics for the Treatment of Substance Use Disorders

BrightView expands its initiative with reSET® and reSET-O® to patients across Kentucky, Ohio, Delaware, Massachusetts, and Virginia Pear Therapeutics, Inc. (NASDAQ:PEAR), the leader in developing and